Aspira Pathlab Diagnostics Ltd vs Kk Shah Hospitals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Aspira Pathlab & Diagnostics Ltd is ₹ 143.34 as of 29 Sep 10:20 . The P/E Ratio of Aspira Pathlab & Diagnostics Ltd is 0 as of March 2024 .The P/E Ratio of KK Shah Hospitals Ltd is 0 as of March 2024 . The Market Cap of Aspira Pathlab & Diagnostics Ltd is ₹ 31.91 crore as of March 2024 .The Market Cap of KK Shah Hospitals Ltd is ₹ 0 crore as of March 2024 . The revenue of Aspira Pathlab & Diagnostics Ltd for the Jun '25 is ₹ 5.36 crore as compare to the Mar '25 revenue of ₹ 5.91 crore. This represent the decline of -9.31% The revenue of KK Shah Hospitals Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Aspira Pathlab & Diagnostics Ltd for the Jun '25 is ₹ 0.79 crore as compare to the Mar '25 ebitda of ₹ 1.05 crore. This represent the decline of -24.76% The ebitda of KK Shah Hospitals Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Aspira Pathlab & Diagnostics Ltd changed from ₹ 0.05 crore to ₹ 0.42 crore over 5 quarters. This represents a CAGR of 448.81% The net profit of KK Shah Hospitals Ltd changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The Dividend Payout of Aspira Pathlab & Diagnostics Ltd changed from 0 % on March 2021 to 0 % on February 2023 . This represents a CAGR of 0.0% over 7 yearsThe Dividend Payout of KK Shah Hospitals Ltd changed from 55.82 % on March 2024 to 0 % on February 2023 . This represents a CAGR of -100.00% over 4 years .

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973.
ASDL is a leading pathology specialist, with Pan-India presence.
It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses.
The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services. Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers.
Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. ASDL ideology is founded on technological supremacy, patient centric approach, and dependable diagnostic results.

About KK Shah Hospitals Ltd

KK Shah Hospitals Limited was incorporated under the name style of 'Jeevan Parv Healthcare Limited' on August 25, 2022 by the Central Registration Center, Manesar.
Subsequently, the Company changed its name from 'Jeevan Parv Healthcare Limited' to 'KK Shah Hospitals Limited' and a fresh certificate of incorporation on November 30, 2022 was issued by the Registrar of Companies, Gwalior, Madhya Pradesh.
The Company is engaged in the providing healthcare services. The Promoter, Dr. Kirti Kumar Shah started a clinic in Ratlam city in the year 1976 which further was transformed into a nursing home in the year 1991.
Subsequently, Dr. Kirti Kumar Shah established pediatrics care unit in 1991 under the name of 'Shah Maternity and Nursing Home'.
He started paediatric unit having Neonatal Intensive Care Unit (NICU) as an integral part of the Clinic in 1994.

FAQs for the comparison of Aspira Pathlab & Diagnostics Ltd and KK Shah Hospitals Ltd

Which company has a larger market capitalization, Aspira Pathlab & Diagnostics Ltd or KK Shah Hospitals Ltd?

Market cap of Aspira Pathlab & Diagnostics Ltd is 129 Cr while Market cap of KK Shah Hospitals Ltd is 30 Cr

What are the key factors driving the stock performance of Aspira Pathlab & Diagnostics Ltd and KK Shah Hospitals Ltd?

The stock performance of Aspira Pathlab & Diagnostics Ltd and KK Shah Hospitals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aspira Pathlab & Diagnostics Ltd and KK Shah Hospitals Ltd?

As of October 25, 2026, the Aspira Pathlab & Diagnostics Ltd stock price is INR ₹126.05. On the other hand, KK Shah Hospitals Ltd stock price is INR ₹45.0.

How do dividend payouts of Aspira Pathlab & Diagnostics Ltd and KK Shah Hospitals Ltd compare?

To compare the dividend payouts of Aspira Pathlab & Diagnostics Ltd and KK Shah Hospitals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.